Fattal Group partners with Kenvue to launch Neutrogena Pharma Range across Levant
This launch builds on Fattal’s long-standing partnership with Kenvue.
LEBANON – Fattal Group’s OTC Healthcare division, a distributor of pharmaceutical, para-pharmaceutical and medical equipment products and services with presence across the Levant, has partnered with Kenvue to launch the Neutrogena Pharma Range in the Levant region.
This is a strategic move that strengthens the brand’s presence in the pharmaceutical and dermatological segments.
This expansion underscores Fattal’s role as a key distributor in the Middle East and North Africa, leveraging its infrastructure to support premium personal care brands.
The high-impact launch occurred on January 15, 2026, at the Phoenicia Hotel in Beirut, drawing over 110 dermatologists, 250 pharmacists, and regional influencers.
Regional Head of OTC, Lena Abi Farah, highlighted Kenvue’s trust in Fattal and the importance of Lebanon’s market during her opening speech.
The event featured interactive elements, including live product competitions with audience voting via QR codes, fostering engagement and brand awareness.
The Neutrogena Pharma Range includes four targeted skincare lines for all ages and skin types: Collagen Bank for pre-aging support, Retinol for fine lines and texture, Anti-Boutons+ for acne-prone skin, and Ultra Sheer for lightweight sun protection.
Top regional dermatologists, including Dr. Roy Moutran, Dr. Constantin El Habr, Dr. Joyce Wehbe, and Dr. Nancy Moufarrej, presented each range, providing scientific validation that boosted credibility among pharmacists.
Attendees, including Iraqi pharmacists and wholesalers, previewed the upcoming Iraq launch, signaling a broader MENA rollout through Fattal’s affiliates, such as Al Mouyasser.
Post-event, commercial teams secured initial orders from pharmacies, positioning Neutrogena Professional as a trusted, dermatologist-endorsed option. Influencers amplified visibility among younger consumers, aligning with Fattal’s values.
This launch builds on Fattal’s operations across Lebanon, Iraq, Jordan, and beyond, enhancing OTC healthcare market penetration.
Meanwhile, earlier this year, Neutrogena launched its “Beauty to a Science” proposition to reaffirm its 90-year scientific heritage in skincare, emphasizing verifiable clinical proof amid consumer demands for transparency.
This initiative positions beauty as an aspiration grounded in evidence-based formulations developed with dermatologists and R&D experts.
The “Beauty to a Science” philosophy merges advanced clinical science with accessible product experiences, ensuring efficacy through rigorous testing without overwhelming consumers with technical details.
Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.
